X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
1. Lutetium (177lu) Chloride
2. 16434-14-3
3. Lutetium Chloride (177lucl3)
4. 1u477369sn
5. Endolucinbeta
6. Lumark
7. Unii-1u477369sn
8. Endolucinbeta (tn)
9. Lutetium (177 Lu) Chloride
10. Lutetium-177 Chloride
11. Dtxsid20167745
12. Lutetium-177 Trichloride
13. Lutetium (177lu) Chloride [who-dd]
14. D10828
15. Q27252884
| Molecular Weight | 283.30 g/mol |
|---|---|
| Molecular Formula | Cl3Lu |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 0 |
| Exact Mass | 281.85032 g/mol |
| Monoisotopic Mass | 281.85032 g/mol |
| Topological Polar Surface Area | 0 Ų |
| Heavy Atom Count | 4 |
| Formal Charge | 0 |
| Complexity | 0 |
| Isotope Atom Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 4 |
EndolucinBeta is a radiopharmaceutical precursor, and it is not intended for direct use in patients. It is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with Lutetium (177Lu) chloride.
Lumark is a radiopharmaceutical precursor. It is not intended for direct use in patients. This medicinal must be used only for the radiolabelling of carrier molecules, which have been specifically developed and authorised for radiolabelling with this radionuclide.
Radiolabelling agent
ilLuzyce is a radiopharmaceutical precursor, and it is not intended for direct use in patients. It is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177Lu) chloride.
V10X
V10
V10X
Market Place
